{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/sentynl-therapeutics-and-mereo-biopharma-announce-option-and-license-agreement-for-alvelestat-in-alpha-1-antitrypsin-deficiency-associated-lung-disease-aatd-ld-302847861.html", "message": "News view counter 875141 successfully enlarged"}